Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Endoscopic Procedures V: ERCP

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301.

ESMO open·2026

Same author

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia.

ESMO gastrointestinal oncology·2026

Same author

Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647].

ESMO open·2025

Same author

Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer.

ESMO open·2024

Same author

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer.

ESMO open·2024

Same author

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.

ESMO open·2024

Search research articles

Related Experiment Video

Updated: May 24, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Postoperative chemoradiotherapy for gallbladder cancer.

K Kim¹, E K Chie, J-Y Jang

¹Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, 110-744, Seoul, Korea.

Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]

|March 10, 2012

Summary

Adjuvant chemoradiotherapy improves survival for gallbladder cancer patients after surgery. Complete tumor resection (R0) is the key factor for long-term survival, even with lymph node involvement.

More Related Videos

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Related Experiment Videos

Last Updated: May 24, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Area of Science:

Oncology
Surgical Oncology
Radiotherapy

Background:

Gallbladder cancer has a poor prognosis, necessitating effective adjuvant therapies post-resection.
Optimizing treatment strategies is crucial for improving survival rates in resected gallbladder cancer.

Purpose of the Study:

To evaluate the efficacy of adjuvant chemoradiotherapy in gallbladder cancer patients post-surgical resection.
To identify prognostic factors influencing survival in this patient cohort.

Main Methods:

A cohort of 47 gallbladder cancer patients received surgery followed by adjuvant radiotherapy (40-50 Gy) with 5-fluorouracil (n=41).
Follow-up was conducted for a median of 48 months.
Prognostic factors including resection extent, T stage, N stage, lymph node dissection, and histology were analyzed.

Main Results:

The 5-year overall survival rate was 43.7%.
Resection extent was the sole significant prognostic factor (p=0.0075), with 5-year survival rates of 52.8% (R0), 20.0% (R1), and 0% (R2).
No significant difference in survival was observed based on lymph node status (N0, N1, Nx) in R0-resected patients (p=0.6246).

Conclusions:

Adjuvant chemoradiotherapy following R0 resection offers good long-term survival for gallbladder cancer patients, including those with lymph node metastases.
This treatment may benefit patients with R0 resection even without lymph node dissection.